Site icon pharmaceutical daily

The Oncology Institute of Hope and Innovation (TOI) Adds Three New Clinics to Tampa Area Footprint Through Acquisition

Addition of Oncology Association Brings TOI to 4 Locations in Tampa Bay and 45 Nationwide

TAMPA, Fla.–(BUSINESS WIRE)–#healthcare–The Oncology Institute of Hope and Innovation (TOI) has completed the acquisition of Oncology Association, operated by Dr. Pedro Mendez, marking TOI’s second acquisition in Florida and expansion into Hillsborough County.

Founded in 2007, TOI is a multi-state cancer care practice dedicated to healing and empowering patients through compassion, innovation, and state-of-the-art medical care. TOI is the largest value-based oncology practice in the U.S., taking accountability for both the quality outcomes as well as the medical costs associated with a population of more than 1 million patients.

Dr. Mendez expressed his enthusiasm about joining the practice by stating, “I am pleased to join TOI and the team of nearly 50 well-respected oncologists. This transition offers our patients an expanded list of services, as well as the expertise of my new colleagues, which I am confident will improve patient care.”

As the nation’s leading value-based oncology provider, TOI offers a diverse set of cutting-edge resources including:

TOI CEO, Brad Hively shared “We are thrilled to welcome Dr. Mendez to our team. With a long history of caring for patients in Hillsborough County, Dr. Mendez brings to TOI a reputation for excellent care as well as deep connections to the local community.”

About The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is one of the largest community oncology practices in the US as well as our nation’s leading value-based oncology services platform. TOI employs 70+ physicians and advanced practice providers in 45+ clinic locations, with more than 500 total employees helping to offer leading-edge, evidence-based cancer care to a population of more than 1 million patients. TOI brings comprehensive, integrated cancer care into community settings, including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care settings. For more information visit www.theoncologyinstitute.com.

Contacts

Julie Korinke

Director, Marketing and Communications

562.735.3226 x.88806

juliekorinke@theoncologyinstitute.com

Exit mobile version